Tomorrow the six weeks is up for patient six. Within two weeks we MIGHT hear something. Perhaps not. I do expect news on the EU patent front. This would be very well accepted. Another month and a Calimmune interim report is due. Then there will likely be board and management changes. It's looking pretty good IMO.